DaVita (DVA)
(Delayed Data from NYSE)
$139.16 USD
+1.75 (1.27%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $139.08 -0.08 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Brokerage Reports
0 items in cart
DaVita Inc. [DVA]
Reports for Purchase
Showing records 221 - 240 ( 289 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid 4Q13 results with management increasing 2014 guidance
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Dialysis Growth Remains Solid as HCP Visibility Begins to Improve
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
CMS finalized rule reflects phase-in period; 2014 OI guidance below the street
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Solid 3Q13 results; 2014 looking like a reset year with mounting headwinds
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
2Q13 largely inline despite soft results at HCP; mgmt increased 2013 guidance
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Fireworks start early as CMS proposed ESRD rule worse than expected
Provider: FELTL & COMPANY
Analyst: WEIGHT M
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Strong 1Q13 results in dialysis services and HCP; outlook unchanged
Provider: FELTL & COMPANY
Analyst: WEIGHT M